Literature DB >> 15583262

Genetic bases of the rifampin resistance phenotype in Brucella spp.

Cinzia Marianelli1, Franco Ciuchini, Michela Tarantino, Paolo Pasquali, Rosanna Adone.   

Abstract

Rifampin is one of the most potent and broad-spectrum antibiotics against bacterial pathogens. Its bactericidal activity is due to its ability to bind to the beta subunit of the DNA-dependent RNA polymerase encoded by the rpoB gene. Mutations of the rpoB gene have been characterized in rifampin-resistant (Rif(r)) strains of Escherichia coli and Mycobacterium tuberculosis. The genetic bases of Rif(r) in Brucella spp. are still unknown. In the present study, the nucleotide sequences of the rpoB gene of the Rif(r) vaccine strain Brucella abortus RB51 and of 20 Rif(r) clones derived in our laboratory from two Brucella melitensis isolates were determined. These sequences were then compared to those of the respective rifampin-susceptible (Rif(s)) parental strains and to the published B. melitensis strain 16M. All Rif(r) strains carried one or more missense mutations mapping in two regions of the rpoB gene. These two "hot" regions were investigated in eight additional Rif(r) Brucella laboratory mutants and in 20 reference Rif(s) Brucella strains. rpoB mutations were found in all Rif(r) mutants. In contrast, no missense mutations were found in any analyzed Rif(s) strains. Our results represent the first from a study of the molecular characterization of rpoB mutations in resistant Brucella strains and provide an additional proof of the association of specific rpoB mutations with the development of the Rif(r) phenotype in prokaryotes. In addition, because of the relationship between Rif(r) and the attenuation of virulence in Brucella spp., studies of virulence in these mutants may provide useful information about the genetic basis of pathogenesis in Brucella.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583262      PMCID: PMC535235          DOI: 10.1128/JCM.42.12.5439-5443.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 A resolution.

Authors:  G Zhang; E A Campbell; L Minakhin; C Richter; K Severinov; S A Darst
Journal:  Cell       Date:  1999-09-17       Impact factor: 41.582

2.  Characterization of the pleiotropic phenotypes of rifampin-resistant rpoB mutants of Escherichia coli.

Authors:  D J Jin; C A Gross
Journal:  J Bacteriol       Date:  1989-09       Impact factor: 3.490

3.  Serologic responses of Brucella abortus strain 19 calfhood-vaccinated cattle following adult vaccination with strain RB51.

Authors:  S C Olsen; D Evans; S G Hennager; N F Cheville; M G Stevens
Journal:  J Vet Diagn Invest       Date:  1996-10       Impact factor: 1.279

4.  The rpoB gene of Mycobacterium tuberculosis.

Authors:  L P Miller; J T Crawford; T M Shinnick
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

5.  Antibody responses to Brucella abortus 2308 in cattle vaccinated with B. abortus RB51.

Authors:  M G Stevens; S C Olsen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

6.  Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase.

Authors:  K Severinov; M Soushko; A Goldfarb; V Nikiforov
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

7.  RifR mutations in the beginning of the Escherichia coli rpoB gene.

Authors:  K Severinov; M Soushko; A Goldfarb; V Nikiforov
Journal:  Mol Gen Genet       Date:  1994-07-25

8.  Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance.

Authors:  M E Levin; G F Hatfull
Journal:  Mol Microbiol       Date:  1993-04       Impact factor: 3.501

9.  Bacterial survival, lymph node changes, and immunologic responses of cattle vaccinated with standard and mutant strains of Brucella abortus.

Authors:  N F Cheville; A E Jensen; S M Halling; F M Tatum; D C Morfitt; S G Hennager; W M Frerichs; G Schurig
Journal:  Am J Vet Res       Date:  1992-10       Impact factor: 1.156

10.  Characterization of rifampin-resistance in pathogenic mycobacteria.

Authors:  D L Williams; C Waguespack; K Eisenach; J T Crawford; F Portaels; M Salfinger; C M Nolan; C Abe; V Sticht-Groh; T P Gillis
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

View more
  24 in total

1.  Intracellular adaptation of Brucella abortus.

Authors:  Julie Lamontagne; Anik Forest; Elena Marazzo; François Denis; Heather Butler; Jean-François Michaud; Lyne Boucher; Ida Pedro; Annie Villeneuve; Dmitri Sitnikov; Karine Trudel; Najib Nassif; Djamila Boudjelti; Fadi Tomaki; Esteban Chaves-Olarte; Caterina Guzmán-Verri; Sylvain Brunet; Alexandra Côté-Martin; Joanna Hunter; Edgardo Moreno; Eustache Paramithiotis
Journal:  J Proteome Res       Date:  2009-03       Impact factor: 4.466

2.  Protective properties of rifampin-resistant rough mutants of Brucella melitensis.

Authors:  R Adone; F Ciuchini; C Marianelli; M Tarantino; C Pistoia; G Marcon; P Petrucci; M Francia; G Riccardi; P Pasquali
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

3.  Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy.

Authors:  Cinzia Marianelli; Caterina Graziani; Carmela Santangelo; Maria Teresa Xibilia; Alida Imbriani; Rosa Amato; Domenico Neri; Mario Cuccia; Sebastiano Rinnone; Vincenzo Di Marco; Franco Ciuchini
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

4.  Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.

Authors:  Yasemin Bayram; Hanifi Korkoca; Cenk Aypak; Mehmet Parlak; Aytekin Cikman; Selcuk Kilic; Mustafa Berktas
Journal:  Int J Med Sci       Date:  2011-03-03       Impact factor: 3.738

5.  In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.

Authors:  Aun Turkmani; Alexandros Ioannidis; Athanasia Christidou; Anna Psaroulaki; Feidias Loukaides; Yiannis Tselentis
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-10-02       Impact factor: 3.944

6.  Potential mechanisms of attenuation for rifampicin-passaged strains of Flavobacterium psychrophilum.

Authors:  Karol Gliniewicz; Mark Wildung; Lisa H Orfe; Gregory D Wiens; Kenneth D Cain; Kevin K Lahmers; Kevin R Snekvik; Douglas R Call
Journal:  BMC Microbiol       Date:  2015-09-16       Impact factor: 3.605

7.  Caspase-2 mediated apoptotic and necrotic murine macrophage cell death induced by rough Brucella abortus.

Authors:  Fang Chen; Yongqun He
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

8.  Whole-Genome Sequencing for Tracing the Genetic Diversity of Brucella abortus and Brucella melitensis Isolated from Livestock in Egypt.

Authors:  Aman Ullah Khan; Falk Melzer; Ashraf E Sayour; Waleed S Shell; Jörg Linde; Mostafa Abdel-Glil; Sherif A G E El-Soally; Mandy C Elschner; Hossam E M Sayour; Eman Shawkat Ramadan; Shereen Aziz Mohamed; Ashraf Hendam; Rania I Ismail; Lubna F Farahat; Uwe Roesler; Heinrich Neubauer; Hosny El-Adawy
Journal:  Pathogens       Date:  2021-06-16

9.  The Antibacterial Activity of Selected Labiatae (Lamiaceae) Essential Oils against Brucella melitensis.

Authors:  Ayman Al-Mariri; Mazen Safi
Journal:  Iran J Med Sci       Date:  2013-03

10.  Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.

Authors:  Javier Ariza; Mile Bosilkovski; Antonio Cascio; Juan D Colmenero; Michael J Corbel; Matthew E Falagas; Ziad A Memish; Mohammad Reza Hasanjani Roushan; Ethan Rubinstein; Nikolaos V Sipsas; Javier Solera; Edward J Young; Georgios Pappas
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.